UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
July
3, 2006
Date
of
Report (Date of Earliest Event Reported)
EESTECH,
INC.
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
000-32863
|
33-0922627
|
(State
or Other Jurisdiction of
|
(Commission
|
(I.R.S.
Employer
|
Incorporation)
|
File
Number )
|
Identification
No.)
|
1260
S. Highway 98, Building 1, Suite H-5
Chino
Valley, Arizona 86323
(Address
of Principal Executive Offices and Zip Code)
(928)
636-6255
(Registrant’s
Telephone Number, Including Area Code)
23011
Moulton Parkway, Suite A-10
Laguna
Hills, California 92653
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
□
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
□
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
□
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
□
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.01
|
Completion
of Acquisition or Disposition of
Assets.
|
This
filing amends the Current Report on Form 8-K filed by EESTech, Inc. on August
3,
2006.
On
July
3, 2006, EESTech, Inc. (the “Company”) completed the acquisition of Methgen Inc.
(“Methgen”) by acquiring 100% of the issued and outstanding shares of common
stock of Methgen. Pursuant to the transaction, the Company issued 763,700 shares
of its common stock to eight shareholders of Methgen. In exchange, the Company
received 763,700 shares of common stock of Methgen.
At
the
time of the acquisition, Methgen held a license for the marketing and production
rights to the Hybrid Coal Gas Turbine (HCGT) intellectual property in the United
States.
The
shares of the Company’s common stock were offered and sold to each of the
shareholders of Methgen in a private placement transaction made in reliance
upon
exemptions from registration pursuant to Section 4(2) under the Securities
Act
of 1933.
As
of
February 2007, the license for the marketing and production rights to the HCGT
intellectual property in the United States was terminated.
Item
3.02
|
Unregistered
Sales of Equity
Securities.
|
The
information set forth in Item 2.01 of this report is incorporated herein by
reference.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
EESTECH,
INC. |
|
|
|
Date: August
29, 2007 |
By: |
/s/ Murray
Bailey |
|
Name:
Murray Bailey |
|
Title: Chief
Executive Officer
|